<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38863829</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.</ArticleTitle><Pagination><StartPage>1384939</StartPage><MedlinePgn>1384939</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1384939</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2024.1384939</ELocationID><Abstract><AbstractText>The novel coronavirus disease 2019 (COVID-19) pandemic outbreak caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has garnered unprecedented global attention. It caused over 2.47 million deaths through various syndromes such as acute respiratory distress, hypercoagulability, and multiple organ failure. The viral invasion proceeds through the ACE2 receptor, expressed in multiple cell types, and in some patients caused serious damage to tissues, organs, immune cells, and the microbes that colonize the gastrointestinal tract (GIT). Some patients who survived the SARS-CoV-2 infection have developed months of persistent long-COVID-19 symptoms or post-acute sequelae of COVID-19 (PASC). Diagnosis of these patients has revealed multiple biological effects, none of which are mutually exclusive. However, the severity of COVID-19 also depends on numerous comorbidities such as obesity, age, diabetes, and hypertension and care must be taken with respect to other multiple morbidities, such as host immunity. Gut microbiota in relation to SARS-CoV-2 immunopathology is considered to evolve COVID-19 progression via mechanisms of biochemical metabolism, exacerbation of inflammation, intestinal mucosal secretion, cytokine storm, and immunity regulation. Therefore, modulation of gut microbiome equilibrium through food supplements and probiotics remains a hot topic of current research and debate. In this review, we discuss the biological complications of the physio-pathological effects of COVID-19 infection, GIT immune response, and therapeutic pharmacological strategies. We also summarize the therapeutic targets of probiotics, their limitations, and the efficacy of preclinical and clinical drugs to effectively inhibit the spread of SARS-CoV-2.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Raj, Bruce, Anbalagan, Srinivasan, Chinnappan, Rajagopal, Khanna, Chandramoorthy and Mani.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raj</LastName><ForeName>Sterlin T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, Ekka Diagnostics, Chennai, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruce</LastName><ForeName>Alexander W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Faculty of Science, University of South Bohemia, &#x10c;esk&#xe9; Bud&#x11b;jovice, Czechia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anbalagan</LastName><ForeName>Muralidharan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Structural &amp; Cellular Biology, Tulane University School of Medicine, New Orleans, LA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srinivasan</LastName><ForeName>Hemalatha</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Life Sciences, B. S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chinnappan</LastName><ForeName>Sasikala</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, University College of Sedaya International UCSI University, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajagopal</LastName><ForeName>Mogana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, University College of Sedaya International UCSI University, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanna</LastName><ForeName>Kushagra</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandramoorthy</LastName><ForeName>Harish C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Clinical Parasitology, College of Medicine, King Khalid University, Abha, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Stem Cell Research, College of Medicine, King Khalid University, Abha, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mani</LastName><ForeName>Ravishankar Ram</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, University College of Sedaya International UCSI University, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="Y">Dysbiosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="N">Probiotics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D041981" MajorTopicYN="N">Gastrointestinal Tract</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">gut dysbiosis</Keyword><Keyword MajorTopicYN="N">gut microbiome</Keyword><Keyword MajorTopicYN="N">immunomodulation</Keyword><Keyword MajorTopicYN="N">probiotics</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>4</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38863829</ArticleId><ArticleId IdType="pmc">PMC11165100</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2024.1384939</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abbasi A. F., Marinkovic A., Prakash S., Sanyaolu A., Smith S. (2022). COVID-19 and the human gut microbiome: an under-recognized association. Chonnam. Med. J. 58, 96&#x2013;101. doi:&#xa0;10.4068/cmj.2022.58.3.96</Citation><ArticleIdList><ArticleId IdType="doi">10.4068/cmj.2022.58.3.96</ArticleId><ArticleId IdType="pmc">PMC9535107</ArticleId><ArticleId IdType="pubmed">36245770</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo-Shaban T., Sharna S. S., Hosie S., Lee C. Y. Q., Balasuriya G. K., McKeown S. J., et al. . (2023). Issues for patchy tissues: defining roles for gut-associated lymphoid tissue in neurodevelopment and disease. J. Neural Transm (Vienna). 130, 269&#x2013;280. doi:&#xa0;10.1007/s00702-022-02561-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-022-02561-x</ArticleId><ArticleId IdType="pmc">PMC10033573</ArticleId><ArticleId IdType="pubmed">36309872</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamo S., Chevrier S., Cervia C., Zurbuchen Y., Raeber M. E., Yang L., et al. . (2021). Profound dysregulation of T cell homeostasis and function in patients with severe covid-19. Allergy. 76, 2866&#x2013;2881. doi:&#xa0;10.1111/all.14866</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14866</ArticleId><ArticleId IdType="pmc">PMC8251365</ArticleId><ArticleId IdType="pubmed">33884644</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal N., Kitano S., Puah G. R. Y., Kittelmann S., Hwang I. Y., Chang M. W. (2023). Microbiome and human health: current understanding, engineering, and enabling technologies. Chem. Rev. 123, 31&#x2013;72. doi:&#xa0;10.1021/acs.chemrev.2c00431</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.2c00431</ArticleId><ArticleId IdType="pmc">PMC9837825</ArticleId><ArticleId IdType="pubmed">36317983</ArticleId></ArticleIdList></Reference><Reference><Citation>Akter S., Tasnim S., Barua R., Choubey M., Arbee S., Mohib M. M., et al. . (2023). The effect of COVID-19 on gut microbiota: exploring the complex interplay and implications for human health. Gastrointest. Disord. 5, 340&#x2013;355. doi:&#xa0;10.3390/gidisord5030028</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/gidisord5030028</ArticleId></ArticleIdList></Reference><Reference><Citation>Ananya F. N., Ahammed M. R., Fahem M. M., Kafle S., Viswanathan M., Desai D., et al. . (2021). Association of intestinal microbial dysbiosis with chronic obstructive pulmonary disease. Cureus. 13, e19343. doi:&#xa0;10.7759/cureus.19343</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.19343</ArticleId><ArticleId IdType="pmc">PMC8653930</ArticleId><ArticleId IdType="pubmed">34909304</ArticleId></ArticleIdList></Reference><Reference><Citation>Anshory M., Effendi R. M. R. A., Kalim H., Dwiyana R. F., Suwarsa O., Nijsten T. E. C., et al. . (2023). Butyrate properties in immune-related diseases: friend or foe? Fermentation 9, 205. doi:&#xa0;10.3390/fermentation9030205</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/fermentation9030205</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A., Somasundaram I., Das D., Jain Manoj S., Banu H., Mitta Suresh P., et al. . (2023). Functional foods: A promising strategy for restoring gut microbiota diversity impacted by SARS-coV-2 variants. Nutrients. 15, 2631. doi:&#xa0;10.3390/nu15112631</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15112631</ArticleId><ArticleId IdType="pmc">PMC10255361</ArticleId><ArticleId IdType="pubmed">37299594</ArticleId></ArticleIdList></Reference><Reference><Citation>Baradaran Ghavami S., Pourhamzeh M., Farmani M., Raftar S. K. A., Shahrokh S., Shpichka A., et al. . (2021). Cross-talk between immune system and microbiota in COVID-19. Expert Rev. Gastroenterol. Hepatol. 15, 1281&#x2013;1294. doi:&#xa0;10.1080/17474124.2021.1991311</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17474124.2021.1991311</ArticleId><ArticleId IdType="pmc">PMC8567289</ArticleId><ArticleId IdType="pubmed">34654347</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes C. O., Jette C. A., Abernathy M. E., Dam K.-M. A., Esswein S. R., Gristick H. B., et al. . (2020). SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature. 588, 682&#x2013;687. doi:&#xa0;10.1038/s41586-020-2852-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2852-1</ArticleId><ArticleId IdType="pmc">PMC8092461</ArticleId><ArticleId IdType="pubmed">33045718</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Raichon L., Venzon M., Klein J., Axelrad J. E., Zhang C., Sullivan A. P., et al. . (2022). Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nat. Commun. 13, 5926. doi:&#xa0;10.1038/s41467-022-33395-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33395-6</ArticleId><ArticleId IdType="pmc">PMC9626559</ArticleId><ArticleId IdType="pubmed">36319618</ArticleId></ArticleIdList></Reference><Reference><Citation>Boechat J. L., Chora I., Morais A., Delgado L. (2021). The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives. Pulmonology. 27, 423&#x2013;437. doi:&#xa0;10.1016/j.pulmoe.2021.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2021.03.008</ArticleId><ArticleId IdType="pmc">PMC8040543</ArticleId><ArticleId IdType="pubmed">33867315</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell C., Kandalgaonkar M. R., Golonka R. M., Yeoh B. S., Vijay-Kumar M., Saha P. (2023). Crosstalk between gut microbiota and host immunity: impact on inflammation and immunotherapy. Biomedicines 11, 294. doi:&#xa0;10.3390/biomedicines11020294</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11020294</ArticleId><ArticleId IdType="pmc">PMC9953403</ArticleId><ArticleId IdType="pubmed">36830830</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M., Rajnik M., Aleem A., Dulebohn S. C., Di Napoli R. (2023). &#x201c;Features, evaluation, and treatment of coronavirus (COVID-19),&#x201d; in StatPearls (StatPearls Publishing, Treasure Island (FL: ).</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>
Chakraborty R. K., Burns B. (2022). Features, evaluation, and treatment of coronavirus (Systemic inflammatory response syndrome. In StatPearls (StatPearls Publishing; ). Available at: http://www.ncbi.nlm.nih.gov/books/NBK547669/.</Citation><ArticleIdList><ArticleId IdType="pubmed">31613449</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty C., Sharma A. R., Bhattacharya M., Dhama K., Lee S. S. (2022). Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity. World J. Gastroenterol. 28, 2802&#x2013;2822. doi:&#xa0;10.3748/wjg.v28.i25.2802</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v28.i25.2802</ArticleId><ArticleId IdType="pmc">PMC9280735</ArticleId><ArticleId IdType="pubmed">35978881</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia J. K. S., Chia A. Y. (2008). Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J. Clin. Pathol. 61, 43&#x2013;48. doi:&#xa0;10.1136/jcp.2007.050054</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2007.050054</ArticleId><ArticleId IdType="pubmed">17872383</ArticleId></ArticleIdList></Reference><Reference><Citation>Choto T. A., Makupe I., Cakana A. Z., Sibanda E. N., Mduluza T. (2019). Excessive neutrophil recruitment promotes typical T-helper 17 responses in coronavirus disease 2019 patients. PloS One 17, e0273186. doi:&#xa0;10.1371/journal.pone.0273186</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0273186</ArticleId><ArticleId IdType="pmc">PMC9387804</ArticleId><ArticleId IdType="pubmed">35980979</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., McCorkell L., Moore Vogel J., Topol E. J. (2023). Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133&#x2013;146. doi:&#xa0;10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S., Meschiari M., Gibellini L., Bellinazzi C., Borella R., Fidanza L., et al. . (2020). Marked T cell activation, senescence, exhaustion and skewing towards Th17 in patients with covid-19 pneumonia. Nat. Commun. 11, 3434. doi:&#xa0;10.1038/s41467-020-17292-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17292-4</ArticleId><ArticleId IdType="pmc">PMC7338513</ArticleId><ArticleId IdType="pubmed">32632085</ArticleId></ArticleIdList></Reference><Reference><Citation>De Clercq E., Li G. (2016). Approved antiviral drugs over the past 50 years. Clin. Microbiol. Rev. 29, 695&#x2013;747. doi:&#xa0;10.1128/CMR.00102-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00102-15</ArticleId><ArticleId IdType="pmc">PMC4978613</ArticleId><ArticleId IdType="pubmed">27281742</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio C., Collins L. F., Malani P. (2020). Long-term health consequences of COVID-19. J. Am. Med. Assoc. 324, 1723&#x2013;1724. doi:&#xa0;10.1001/jama.2020.19719</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y. Q., Zhang N.-N., Zhang Y.-F., Zhong X., Xu S., Qiu H.-Y., et al. . (2022). Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters. Cell Res. 32, 375&#x2013;382. doi:&#xa0;10.1038/s41422-022-00630-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-022-00630-0</ArticleId><ArticleId IdType="pmc">PMC8866932</ArticleId><ArticleId IdType="pubmed">35210606</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar D., Mohanty A. (2020). Gut microbiota and covid-19- possible link and implications. Virus Res. 285, 198018. doi:&#xa0;10.1016/j.virusres.2020.198018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198018</ArticleId><ArticleId IdType="pmc">PMC7217790</ArticleId><ArticleId IdType="pubmed">32430279</ArticleId></ArticleIdList></Reference><Reference><Citation>Fakharian F., Thirugnanam S., Welsh D. A., Kim W. K., Rappaport J., Bittinger K., et al. . (2023). The role of gut dysbiosis in the loss of intestinal immune cell functions and viral pathogenesis. Microorganisms 11, 1849. doi:&#xa0;10.3390/microorganisms11071849</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11071849</ArticleId><ArticleId IdType="pmc">PMC10384393</ArticleId><ArticleId IdType="pubmed">37513022</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathi F., Sami R., Mozafarpoor S., Hafezi H., Motedayyen H., Arefnezhad R., et al. . (2020). Immune system changes during covid-19 recovery play key role in determining disease severity. Int. J. Immunopathol. Pharmacol. 34, 1-13. doi:&#xa0;10.1177/2058738420966497</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2058738420966497</ArticleId><ArticleId IdType="pmc">PMC7594220</ArticleId><ArticleId IdType="pubmed">33076729</ArticleId></ArticleIdList></Reference><Reference><Citation>Focosi D., Franchini M., Pirofski L.-A., Burnouf T., Paneth N., Joyner M. J., et al. . (2022). COVID-19 convalescent plasma and clinical trials: understanding conflicting outcomes. Clin. Microbiol. Rev. 35, e0020021. doi:&#xa0;10.1128/cmr.00200-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cmr.00200-21</ArticleId><ArticleId IdType="pmc">PMC9491201</ArticleId><ArticleId IdType="pubmed">35262370</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghimire S., Roy C., Wongkuna S., Antony L., Maji A., Keena M. C., et al. . (2020). Identification of Clostridioides difficile-inhibiting gut commensals using culturomics, phenotyping, and combinatorial community assembly. mSystems. 5, e00620&#x2013;e00619. doi:&#xa0;10.1128/mSystems.00620-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSystems.00620-19</ArticleId><ArticleId IdType="pmc">PMC7002114</ArticleId><ArticleId IdType="pubmed">32019832</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons S. M., Gurry T., Lampe J. W., Chakrabarti A., Dam V., Everard A., et al. . (2022). Perspective: leveraging the gut microbiota to predict personalized responses to dietary, prebiotic, and probiotic interventions. Adv. Nutr. 2, 13(5):1450&#x2013;1461. doi:&#xa0;10.1093/advances/nmac075</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmac075</ArticleId><ArticleId IdType="pmc">PMC9526856</ArticleId><ArticleId IdType="pubmed">35776947</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil-Etayo F. J., Suarez-Fernandez P., Cabrera-Marante O., Arroyo D., Garcinuno S., Naranjo. L., et al. . (2021). T-Helper cell subset response is a determining factor in covid-19 progression. Front. Cell Infect. Microbiol. 11. doi:&#xa0;10.3389/fcimb.2021.624483</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.624483</ArticleId><ArticleId IdType="pmc">PMC7952877</ArticleId><ArticleId IdType="pubmed">33718270</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron L. B., Dweep H., Yin X., Wang H., Damra M., Goldman A. R., et al. . (2021). Plasma markers of disrupted gut permeability in severe COVID-19 patients. Front. Immunol. 12, 686240. doi:&#xa0;10.3389/fimmu.2021.686240</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686240</ArticleId><ArticleId IdType="pmc">PMC8219958</ArticleId><ArticleId IdType="pubmed">34177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannoodee S., Nasuruddin D. N. (2022). &#x201c;Acute inflammatory response,&#x201d; in StatPearls (StatPearls Publishing, Treasure Island (FL: ).</Citation></Reference><Reference><Citation>Harper A., Vijayakumar V., Ouwehand A. C., ter Haar J., Obis D., Espadaler J., et al. . (2021). Viral infections, the microbiome, and probiotics. Front. Cell. Infect. Microbiol. 10. doi:&#xa0;10.3389/fcimb.2020.596166</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.596166</ArticleId><ArticleId IdType="pmc">PMC7907522</ArticleId><ArticleId IdType="pubmed">33643929</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazan S., Stollman N., Bozkurt H. S., Dave S., Papoutsis A. J., Daniels J., et al. . (2022). Lost microbes of covid-19: bifidobacterium, faecalibacterium depletion and decreased microbiome diversity associated with sars-Cov-2 infection severity. BMJ Open Gastroenterol. 9, e000871. doi:&#xa0;10.1136/bmjgast-2022-000871</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgast-2022-000871</ArticleId><ArticleId IdType="pmc">PMC9051551</ArticleId><ArticleId IdType="pubmed">35483736</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermens J. M., Kesmir C. (2023). Role of T cells in severe COVID-19 disease, protection, and long term immunity. Immunogenetics. 75, 295&#x2013;307. doi:&#xa0;10.1007/s00251-023-01294-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00251-023-01294-9</ArticleId><ArticleId IdType="pmc">PMC9905767</ArticleId><ArticleId IdType="pubmed">36752852</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. . (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 397, 220&#x2013;232. doi:&#xa0;10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang B., Wang J., Li L. (2023). Recent five-year progress in the impact of gut microbiota on vaccination and possible mechanisms. Gut Pathog. 15, 27. doi:&#xa0;10.1186/s13099-023-00547-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-023-00547-y</ArticleId><ArticleId IdType="pmc">PMC10258485</ArticleId><ArticleId IdType="pubmed">37308966</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung Y. P., Lee C. C., Lee J. C., Tsai P. J., Ko W. C. (2021). Gut dysbiosis during COVID-19 and potential effect of probiotics. Microorganisms 9, 1605. doi:&#xa0;10.3390/microorganisms9081605</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9081605</ArticleId><ArticleId IdType="pmc">PMC8402052</ArticleId><ArticleId IdType="pubmed">34442684</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain I., Cher G. L. Y., Abid M. A., Abid M. B. (2021). Role of gut microbiome in COVID-19: an insight into pathogenesis and therapeutic potential. Front. Immunol. 12. doi:&#xa0;10.3389/fimmu.2021.765965</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.765965</ArticleId><ArticleId IdType="pmc">PMC8551858</ArticleId><ArticleId IdType="pubmed">34721437</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer A. S., Jones F. K., Nodoushani A., Kelly M., Becker M., Slater D., et al. . (2020). Persistence and decay of human antibody responses to the receptor binding domain of sars-Cov-2 spike protein in covid-19 patients. Sci. Immunol. 5, eabe0367. doi:&#xa0;10.1126/sciimmunol.abe0367</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abe0367</ArticleId><ArticleId IdType="pmc">PMC7857394</ArticleId><ArticleId IdType="pubmed">33033172</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz-Agranov N., Zandman-Goddard G. (2021). Autoimmunity and covid-19 &#x2013; the microbiotal connection. Autoimmun Rev. 20, 102865. doi:&#xa0;10.1016/j.autrev.2021.102865</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102865</ArticleId><ArticleId IdType="pmc">PMC8189735</ArticleId><ArticleId IdType="pubmed">34118455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C., Freitag H., Meyer-Arndt L.-A., Wittke K., Zoller T., Steinbeis F., et al. . (2021). Chronic COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) following the first pandemic wave in Germany: a first analysis of a prospective observational study. Med. Rxiv, 1-23. doi:&#xa0;10.1101/2021.02.06.21249256v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.06.21249256v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G., Townsend L., Savinelli S., Mallon P. W. G. (2023). Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets. Front. Mol. Biosci. 10. doi:&#xa0;10.3389/fmolb.2023.1157651</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2023.1157651</ArticleId><ArticleId IdType="pmc">PMC10171433</ArticleId><ArticleId IdType="pubmed">37179568</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Mathew B. J., Gupta P., Garg G., Khadanga S., Vyas A. K., et al. . (2021). Gut dysbiosis and il-21 response in patients with severe covid-19. Microorganisms. 9, 1292. doi:&#xa0;10.3390/microorganisms9061292</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9061292</ArticleId><ArticleId IdType="pmc">PMC8231954</ArticleId><ArticleId IdType="pubmed">34199203</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A. L., Bateman L. (2021). Will COVID-19 lead to myalgicencephalomyelitis/chronic fatigue syndrome? Front. Med. 7, 606824. doi:&#xa0;10.3389/fmed.2020.606824</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruglikov I. L., Shah M., Scherer P. E. (2020). Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions. Elife. 9, e61330. doi:&#xa0;10.7554/eLife.61330</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.61330</ArticleId><ArticleId IdType="pmc">PMC7492082</ArticleId><ArticleId IdType="pubmed">32930095</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M. M., Beumer J., van der Vaart J., Knoops K., Puschhof J., Breugem T. I., et al. . (2020). SARS-CoV-2 productively infects human gut enterocytes. Science. 369, 50&#x2013;54. doi:&#xa0;10.1126/science.abc1669</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W. S., Wheatley A. K., Kent S. J., DeKosky B. J. (2020). Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat. Microbiol. 5, 1185&#x2013;1191. doi:&#xa0;10.1038/s41564-020-00789-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-00789-5</ArticleId><ArticleId IdType="pubmed">32908214</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Chen W., Lin F., Li W., Wang P., Liao G., et al. . (2023). Functional two-way crosstalk between brain and lung: the brain-lung axis. Cell Mol. Neurobiol. 43, 991&#x2013;1003. doi:&#xa0;10.1007/s10571-022-01238-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-022-01238-z</ArticleId><ArticleId IdType="pmc">PMC9178545</ArticleId><ArticleId IdType="pubmed">35678887</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang B., Xing D. (2023). The current and future perspectives of postbiotics. Probiotics Antimicro. Prot 15 (6), 1626-1643. doi:&#xa0;10.1007/s12602-023-10045-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12602-023-10045-x</ArticleId><ArticleId IdType="pmc">PMC9913028</ArticleId><ArticleId IdType="pubmed">36763279</ArticleId></ArticleIdList></Reference><Reference><Citation>Lionakis M. S., Drummond R. A., Hohl. T. M. (2023). Immune responses to human fungal pathogens and therapeutic prospects. Nat. Rev. Immunol. 23, 433&#x2013;452. doi:&#xa0;10.1038/s41577-022-00826-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00826-w</ArticleId><ArticleId IdType="pmc">PMC9812358</ArticleId><ArticleId IdType="pubmed">36600071</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Cheng Y., Zang D., Zhang M., Li X., Liu D., et al. . (2021). The role of gut microbiota in lung cancer: from carcinogenesis to immunotherapy. Front. Oncol. 11. doi:&#xa0;10.3389/fonc.2021.720842</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.720842</ArticleId><ArticleId IdType="pmc">PMC8417127</ArticleId><ArticleId IdType="pubmed">34490119</ArticleId></ArticleIdList></Reference><Reference><Citation>Low R. N., Low R. J., Akrami A. (2023). A review of cytokine-based pathophysiology of Long COVID symptoms. Front. Med. (Lausanne). 10. doi:&#xa0;10.3389/fmed.2023.1011936</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma&#x144;kowska-Wierzbicka D., Zuraszek J., Wierzbicka A., Gabryel M., Mahadea D., Baturo A., et al. . (2023). Alterations in gut microbiota composition in patients with COVID-19: A pilot study of whole hypervariable 16S rRNA gene sequencing. Biomedicines 11, 367. doi:&#xa0;10.3390/biomedicines11020367</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11020367</ArticleId><ArticleId IdType="pmc">PMC9953267</ArticleId><ArticleId IdType="pubmed">36830905</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazhar M., Zhu Y., Qin L. (2023). The interplay of dietary fibers and intestinal microbiota affects type 2 diabetes by generating short-chain fatty acids. Foods 12, 1023. doi:&#xa0;10.3390/foods12051023</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods12051023</ArticleId><ArticleId IdType="pmc">PMC10001013</ArticleId><ArticleId IdType="pubmed">36900540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazziotta C., Tognon M., Martini F., Torreggiani E., Rotondo J. C. (2023). Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells. 12, 184. doi:&#xa0;10.3390/cells12010184</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12010184</ArticleId><ArticleId IdType="pmc">PMC9818925</ArticleId><ArticleId IdType="pubmed">36611977</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoni A., Salvati L., Maggi L., Capone M., Vanni A., Spinicci M., et al. . (2020). Impaired immune cell cytotoxicity in severe covid-19 is il-6 dependent. J. Clin. Invest. 130, 4694&#x2013;4703. doi:&#xa0;10.1172/JCI138554</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI138554</ArticleId><ArticleId IdType="pmc">PMC7456250</ArticleId><ArticleId IdType="pubmed">32463803</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahan K., Yu J., Mercado N. B., Loos C., Tostanoski L. H., Chandrashekar A., et al. . (2021). Correlates of protection against sars-Cov-2 in rhesus macaques. Nature. 590, 630&#x2013;634. doi:&#xa0;10.1038/s41586-020-03041-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03041-6</ArticleId><ArticleId IdType="pmc">PMC7906955</ArticleId><ArticleId IdType="pubmed">33276369</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohandas S., Jagannathan P., Henrich T. J., Sherif Z. A., Bime C., Quinlan E., et al. . (2023). RECOVER Mechanistic Pathways Task Force. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 12, e86014. doi:&#xa0;10.7554/eLife.86014</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86014</ArticleId><ArticleId IdType="pmc">PMC10219649</ArticleId><ArticleId IdType="pubmed">37233729</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazersaheb S., Hosseiniyan Khatibi S. M., Hejazi M. S., Tarhriz V., Farjami A., Ghasemian Sorbeni F., et al. . (2022). COVID-19 infection: an overview on cytokine storm and related interventions. Virol. J. 19, 92. doi:&#xa0;10.1186/s12985-022-01814-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01814-1</ArticleId><ArticleId IdType="pmc">PMC9134144</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller L., Di Benedetto S. (2023). Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions. Immun. Ageing 20, 17. doi:&#xa0;10.1186/s12979-023-00341-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-023-00341-z</ArticleId><ArticleId IdType="pmc">PMC10090758</ArticleId><ArticleId IdType="pubmed">37046272</ArticleId></ArticleIdList></Reference><Reference><Citation>Nejadghaderi S. A., Nazemalhosseini-Mojarad E., Asadzadeh Aghdaei H. (2021). Fecal microbiota transplantation for covid-19; a potential emerging treatment strategy. Med. Hypotheses. 147, 110476. doi:&#xa0;10.1016/j.mehy.2020.110476</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110476</ArticleId><ArticleId IdType="pmc">PMC7774521</ArticleId><ArticleId IdType="pubmed">33482620</ArticleId></ArticleIdList></Reference><Reference><Citation>Newberry F., Hsieh S. Y., Wileman T., Carding S. R. (2018). Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome? Clin. Sci. 132, 523&#x2013;542. doi:&#xa0;10.1042/cs20171330</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/cs20171330</ArticleId><ArticleId IdType="pmc">PMC5843715</ArticleId><ArticleId IdType="pubmed">29523751</ArticleId></ArticleIdList></Reference><Reference><Citation>Opsteen S., Files J. K., Fram T., Erdmann N. (2023). The role of immune activation and antigen persistence in acute and long COVID. J. Investig. Med. 71, 545&#x2013;562. doi:&#xa0;10.1177/10815589231158041</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10815589231158041</ArticleId><ArticleId IdType="pmc">PMC9996119</ArticleId><ArticleId IdType="pubmed">36879504</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantazi A. C., Balasa A. L., Mihai C. M., Chisnoiu T., Lupu V. V., Kassim M. A. K., et al. . (2023). Development of gut microbiota in the first 1000 days after birth and potential interventions. Nutrients 15, 3647. doi:&#xa0;10.3390/nu15163647</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15163647</ArticleId><ArticleId IdType="pmc">PMC10457741</ArticleId><ArticleId IdType="pubmed">37630837</ArticleId></ArticleIdList></Reference><Reference><Citation>Parackova Z., Bloomfield M., Klocperk A., Sediva A. (2021). Neutrophils mediate Th17 promotion in covid-19 patients. J. Leukocyte Biol. 109, 73&#x2013;76. doi:&#xa0;10.1002/JLB.4COVCRA0820-481RRR</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4COVCRA0820-481RRR</ArticleId><ArticleId IdType="pmc">PMC7753339</ArticleId><ArticleId IdType="pubmed">33289169</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J. I., Cho S. W., Kang J. H., Park T. E. (2023). Intestinal peyer's patches: structure, function, and in vitro modeling. Tissue Eng. Regener. Med. 20, 341&#x2013;353. doi:&#xa0;10.1007/s13770-023-00543-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13770-023-00543-y</ArticleId><ArticleId IdType="pmc">PMC10117255</ArticleId><ArticleId IdType="pubmed">37079198</ArticleId></ArticleIdList></Reference><Reference><Citation>Pheeha S. M., Tamuzi J. L., Chale-Matsau B., Manda S., Nyasulu P. S. A. (2023). Scoping review evaluating the current state of gut microbiota research in Africa. Microorganisms 11, 2118. doi:&#xa0;10.3390/microorganisms11082118</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11082118</ArticleId><ArticleId IdType="pmc">PMC10458939</ArticleId><ArticleId IdType="pubmed">37630678</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccioni A., Covino M., Candelli M., Ojetti V., Capacci A., Gasbarrini A., et al. . (2023). How do diet patterns, single foods, prebiotics and probiotics impact gut microbiota? Microbiol. Res. 14, 390&#x2013;408. doi:&#xa0;10.3390/microbiolres14010030</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microbiolres14010030</ArticleId></ArticleIdList></Reference><Reference><Citation>Pircalabioru G. G., Savu O., Mihaescu G., Vrancianu C. O., Chifiriuc M.-C. (2022). Dysbiosis, tolerance, and development of autoimmune diseases. Immunology of the GI tract - recent advances. IntechOpen. doi:&#xa0;10.5772/intechopen.101293</Citation><ArticleIdList><ArticleId IdType="doi">10.5772/intechopen.101293</ArticleId></ArticleIdList></Reference><Reference><Citation>Portincasa P., Bonfrate L., Vacca M., De Angelis M., Farella I., Lanza E., et al. . (2022). Gut microbiota and short chain fatty acids: implications in glucose homeostasis. Int. J. Mol. Sci. 23, 1105. doi:&#xa0;10.3390/ijms23031105</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031105</ArticleId><ArticleId IdType="pmc">PMC8835596</ArticleId><ArticleId IdType="pubmed">35163038</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A. D., VanElzakker M. B. (2021). Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 12, 312. doi:&#xa0;10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaranta G., Guarnaccia A., Fancello G., Agrillo C., Iannarelli F., Sanguinetti M., et al. . (2022). Fecal microbiota transplantation and other gut microbiota manipulation strategies. Microorganisms 10, 2424. doi:&#xa0;10.3390/microorganisms10122424</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10122424</ArticleId><ArticleId IdType="pmc">PMC9781458</ArticleId><ArticleId IdType="pubmed">36557677</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralli T., Saifi Z., Rathee A., Aeri V., Kohli K. (2023). Decoding the bidirectional relationship between gut microbiota and COVID-19. Heliyon. 9, e13801. doi:&#xa0;10.1016/j.heliyon.2023.e13801</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e13801</ArticleId><ArticleId IdType="pmc">PMC9936796</ArticleId><ArticleId IdType="pubmed">36811017</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S., Nora-Krukle Z., Henning N., Eliassen E., Shikova E., Harrer T., et al. . (2018). Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J. Transl. Med. 16, 268. doi:&#xa0;10.1186/s12967-018-1644-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray M., Manjunath A., Halami P. M. (2023). Effect of probiotics as an immune modulator for the management of COVID-19. Arch. Microbiol. 205, 182. doi:&#xa0;10.1007/s00203-023-03504-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00203-023-03504-0</ArticleId><ArticleId IdType="pmc">PMC10098245</ArticleId><ArticleId IdType="pubmed">37031431</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodda L. B., Netland J., Shehata L., Pruner K. B., Morawski P. A., Thouvenel C. D., et al. . (2021). Functional sars-Cov-2-Specific immune memory persists after mild covid-19. Cell. 184, 169&#x2013;83.e17. doi:&#xa0;10.1016/j.cell.2020.11.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.029</ArticleId><ArticleId IdType="pmc">PMC7682481</ArticleId><ArticleId IdType="pubmed">33296701</ArticleId></ArticleIdList></Reference><Reference><Citation>Samavati L., Uhal B. D. (2020). ACE2, much more than just a receptor for SARS-COV-2. Front. Cell. Infect. Microbiol. 10. doi:&#xa0;10.3389/fcimb.2020.00317</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00317</ArticleId><ArticleId IdType="pmc">PMC7294848</ArticleId><ArticleId IdType="pubmed">32582574</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanekommu H., Taj S., Mah Noor R., Umair Akmal M., Akhtar R., Hossain M., et al. . (2023). Probiotics and fecal transplant: an intervention in delaying chronic kidney disease progression? Clin. Pract. 13, 881&#x2013;888. doi:&#xa0;10.3390/clinpract13040080</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/clinpract13040080</ArticleId><ArticleId IdType="pmc">PMC10453439</ArticleId><ArticleId IdType="pubmed">37623261</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine T., Perez-Potti A., Rivera-Ballesteros O., Stralin K., Gorin J. B., Olsson A., et al. . (2020). Robust T cell immunity in convalescent individuals with asymptomatic or mild covid-19. Cell. 183, 158&#x2013;68.e14. doi:&#xa0;10.1016/j.cell.2020.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.017</ArticleId><ArticleId IdType="pmc">PMC7427556</ArticleId><ArticleId IdType="pubmed">32979941</ArticleId></ArticleIdList></Reference><Reference><Citation>Senefeld J. W., Casadevall A., Joyner M. J. (2022). Convalescent plasma to deliver therapeutic antibodies against COVID-19. Trends Mol. Med. 28, 435&#x2013;436. doi:&#xa0;10.1016/j.molmed.2022.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2022.02.005</ArticleId><ArticleId IdType="pmc">PMC8858694</ArticleId><ArticleId IdType="pubmed">35248476</ArticleId></ArticleIdList></Reference><Reference><Citation>SeyedAlinaghi S., Afzalian A., Pashaei Z., Varshochi S., Karimi A., Mojdeganlou H., et al. . (2023). Gut microbiota and COVID-19: A systematic review. Health Sci. Rep. 6, e1080. doi:&#xa0;10.1002/hsr2.1080</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.1080</ArticleId><ArticleId IdType="pmc">PMC9881458</ArticleId><ArticleId IdType="pubmed">36721396</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif Z. A., Gomez C. R., Connors T. J., Henrich T. J., Reeves W. B. (2023). Recover Mechanistic Pathway Task Force. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 12, e86002. doi:&#xa0;10.7554/eLife.86002</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Song Z. G., Liu C., Tan S., Lin S., Zhu J., et al. . (2022). Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in covid-19 patients. BMC Med. 20, 24. doi:&#xa0;10.1186/s12916-021-02212-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02212-0</ArticleId><ArticleId IdType="pmc">PMC8769945</ArticleId><ArticleId IdType="pubmed">35045853</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao W., Zhang G., Wang X., Guo M., Zeng W., Xu Z., et al. . (2020). Analysis of the intestinal microbiota in covid-19 patients and its correlation with the inflammatory factor il-18. Med. Microecology. 5, 100023. doi:&#xa0;10.1016/j.medmic.2020.100023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medmic.2020.100023</ArticleId><ArticleId IdType="pmc">PMC7832617</ArticleId><ArticleId IdType="pubmed">34173452</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavakol Z., Ghannadi S., Tabesh M. R., Halabchi F., Noormohammadpour P., Akbarpour S., et al. . (2023). Relationship between physical activity, healthy lifestyle and COVID-19 disease severity; a cross-sectional study. Z Gesundh Wiss 31, 267&#x2013;275. doi:&#xa0;10.1007/s10389-020-01468-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10389-020-01468-9</ArticleId><ArticleId IdType="pmc">PMC7858040</ArticleId><ArticleId IdType="pubmed">33558839</ArticleId></ArticleIdList></Reference><Reference><Citation>Tieu V., Tibi S., Ling J. (2023). Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota. Front. Cell. Infect. Microbiol. 13. doi:&#xa0;10.3389/fcimb.2023.1167827</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1167827</ArticleId><ArticleId IdType="pmc">PMC10339388</ArticleId><ArticleId IdType="pubmed">37457959</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirelli C., De Amici M., Albrici C., Mira S., Nalesso G., Re B., et al. . (2023). Exploring the role of immune system and inflammatory cytokines in SARS-coV-2 induced lung disease. A Narrative Review. Biol. 12, 177. doi:&#xa0;10.3390/biology12020177</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology12020177</ArticleId><ArticleId IdType="pmc">PMC9953200</ArticleId><ArticleId IdType="pubmed">36829456</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomkinson S., Triscott C., Schenk E., Foey A. (2023). The potential of probiotics as ingestible adjuvants and immune modulators for antiviral immunity and management of SARS-coV-2 infection and COVID-19. Pathogens 12, 928. doi:&#xa0;10.3390/pathogens12070928</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12070928</ArticleId><ArticleId IdType="pmc">PMC10384479</ArticleId><ArticleId IdType="pubmed">37513775</ArticleId></ArticleIdList></Reference><Reference><Citation>Toor D., Wsson M. K., Kumar P., Karthikeyan G., Kaushik N. K., Goel C., et al. . (2019). Dysbiosis disrupts gut immune homeostasis and promotes gastric diseases. Int. J. Mol. Sci. 20, 2432. doi:&#xa0;10.3390/ijms20102432</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20102432</ArticleId><ArticleId IdType="pmc">PMC6567003</ArticleId><ArticleId IdType="pubmed">31100929</ArticleId></ArticleIdList></Reference><Reference><Citation>Troisi A. (2023). Mental health challenges during the COVID-19 pandemic. J. Clin. Med. 12 (3), 1213. doi:&#xa0;10.3390/jcm12031213</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12031213</ArticleId><ArticleId IdType="pmc">PMC9917975</ArticleId><ArticleId IdType="pubmed">36769860</ArticleId></ArticleIdList></Reference><Reference><Citation>Troisi J., Venutolo G., Pujolassos, Tany&#xe0; M., Delli Carri M., Landolfi A., Fasano A. (2021). COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection? World J. Gastroenterol. 27, 1406&#x2013;1418. doi:&#xa0;10.3748/wjg.v27.i14.1406</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v27.i14.1406</ArticleId><ArticleId IdType="pmc">PMC8047540</ArticleId><ArticleId IdType="pubmed">33911464</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzzan M., Corcos O., Martin J. C., Treton X., Bouhnik Y. (2020). Why is sars-Cov-2 infection more severe in obese men? the gut lymphatics - lung axis hypothesis. Med. Hypotheses. 144, 110023. doi:&#xa0;10.1016/j.mehy.2020.110023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110023</ArticleId><ArticleId IdType="pmc">PMC7308746</ArticleId><ArticleId IdType="pubmed">32593832</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm L. K., Nielsen S. S., Pahus M. H., Frattari G. S., Olesen R., Andersen R., et al. . (2021). SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine. 64, 103230. doi:&#xa0;10.1016/j.ebiom.2021.103230</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103230</ArticleId><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Vojdani E., Saidara E., Maes M. (2023). Persistent SARS-coV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID. Viruses 15, 400. doi:&#xa0;10.3390/v15020400</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020400</ArticleId><ArticleId IdType="pmc">PMC9967513</ArticleId><ArticleId IdType="pubmed">36851614</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Cai Y., Garssen J., Henricks P. A. J., Folkerts G., Braber S. (2023). The bidirectional gut-lung axis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 207, 1145&#x2013;1160. doi:&#xa0;10.1164/rccm.202206-1066TR</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202206-1066TR</ArticleId><ArticleId IdType="pmc">PMC10161745</ArticleId><ArticleId IdType="pubmed">36883945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Jiang M., Chen X., Montaner L. J. (2020). Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J. Leukoc. Biol. 108, 17&#x2013;41. doi:&#xa0;10.1002/JLB.3COVR0520-272R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3COVR0520-272R</ArticleId><ArticleId IdType="pmc">PMC7323250</ArticleId><ArticleId IdType="pubmed">32534467</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Zhang Y., Li C., Chang W., Zhang L. (2023). The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment. Front. Immunol. 14. doi:&#xa0;10.3389/fimmu.2023.1180336</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1180336</ArticleId><ArticleId IdType="pmc">PMC10185909</ArticleId><ArticleId IdType="pubmed">37205106</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Cheng X., Jiang G., Tang H., Ming S., Tang L., et al. . (2021. b). Altered oral and gut microbiota and its association with sars-Cov-2 viral load in covid-19 patients during hospitalization. NPJ Biofilms Microbiomes. 7, 61. doi:&#xa0;10.1038/s41522-021-00232-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41522-021-00232-5</ArticleId><ArticleId IdType="pmc">PMC8298611</ArticleId><ArticleId IdType="pubmed">34294722</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Xu Q., Cao Z., Pan D., Zhu Y., Wang S., et al. . (2021. a). The volatile and heterogeneous gut microbiota shifts of covid-19 patients over the course of a probiotics-assisted therapy. Clin. Trans. Med. 11, e643. doi:&#xa0;10.1002/ctm2.643</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.643</ArticleId><ArticleId IdType="pmc">PMC8713143</ArticleId><ArticleId IdType="pubmed">34962356</ArticleId></ArticleIdList></Reference><Reference><Citation>Wylie K. M., Mihindukulasuriya K. A., Zhou Y., Sodergren E., Storch G. A., Weinstock G. M. (2014). Metagenomic analysis of double-stranded DNA viruses in healthy adults. BMC Med. 12, 71. doi:&#xa0;10.1186/s12915-014-0071-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-014-0071-7</ArticleId><ArticleId IdType="pmc">PMC4177058</ArticleId><ArticleId IdType="pubmed">25212266</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang H., Liu Q. P. (2022). Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential. World J. Gastroenterol. 28, 6689&#x2013;6701. doi:&#xa0;10.3748/wjg.v28.i47.6689</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v28.i47.6689</ArticleId><ArticleId IdType="pmc">PMC9813939</ArticleId><ArticleId IdType="pubmed">36620345</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong R. G., Li J., Cheng J., Zhou D. D., Wu S. X., Huang S. Y., et al. . (2023). The role of gut microbiota in anxiety, depression, and other mental disorders as well as the protective effects of dietary components. Nutrients 15, 3258. doi:&#xa0;10.3390/nu15143258</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15143258</ArticleId><ArticleId IdType="pmc">PMC10384867</ArticleId><ArticleId IdType="pubmed">37513676</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Zhang W., Guo M., Xiao C., Fu Z., Yu S., et al. . (2022). Integrated analysis of gut microbiome and host immune responses in covid-19. Front. Med. 16, 263&#x2013;275. doi:&#xa0;10.1007/s11684-022-0921-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-022-0921-6</ArticleId><ArticleId IdType="pmc">PMC8902486</ArticleId><ArticleId IdType="pubmed">35258762</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto S., Saito M., Tamura A., Prawisuda D., Mizutani T., Yotsuyanagi H. (2021). The human microbiome and COVID-19: A systematic review. PloS One 16, e0253293. doi:&#xa0;10.1371/journal.pone.0253293</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253293</ArticleId><ArticleId IdType="pmc">PMC8221462</ArticleId><ArticleId IdType="pubmed">34161373</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y. K., Zuo T., Lui G. C., Zhang F., Liu Q., Li A. Y., et al. . (2021). Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with covid-19. Gut. 70, 698&#x2013;706. doi:&#xa0;10.1136/gutjnl-2020-323020</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuksel N., Gelmez B., Yildiz-Pekoz A. (2023). Lung microbiota: its relationship to respiratory system diseases and approaches for lung-targeted probiotic bacteria delivery. Mol. Pharmaceutics 20, 3320&#x2013;3337. doi:&#xa0;10.1021/acs.molpharmaceut.3c00323</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.molpharmaceut.3c00323</ArticleId><ArticleId IdType="pmc">PMC10324390</ArticleId><ArticleId IdType="pubmed">37340968</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Lau R. I., Liu Q., Su Q., Chan F. K. L., Ng S. C. (2023). Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 20, 323&#x2013;337. doi:&#xa0;10.1038/s41575-022-00698-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00698-4</ArticleId><ArticleId IdType="pmc">PMC9589856</ArticleId><ArticleId IdType="pubmed">36271144</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Feng P., Meng W., Jin W., Li X., Li X. (2022). Modulated gut microbiota for potential COVID-19 prevention and treatment. Front. Med. 9. doi:&#xa0;10.3389/fmed.2022.811176</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.811176</ArticleId><ArticleId IdType="pmc">PMC8927624</ArticleId><ArticleId IdType="pubmed">35308540</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng D., Liwinski T., Elinav E. (2020). Interaction between microbiota and immunity in health and disease. Cell Res. 30, 492&#x2013;506. doi:&#xa0;10.1038/s41422-020-0332-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0332-7</ArticleId><ArticleId IdType="pmc">PMC7264227</ArticleId><ArticleId IdType="pubmed">32433595</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Shi X., Fu W., Xiang F., He X., Yang B., et al. . (2021). Gut microbiota dysbiosis correlates with abnormal immune response in moderate covid-19 patients with fever. J. Inflammation Res. 14, 2619&#x2013;2631. doi:&#xa0;10.2147/JIR.S311518</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S311518</ArticleId><ArticleId IdType="pmc">PMC8217908</ArticleId><ArticleId IdType="pubmed">34168484</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>